市場調查報告書
商品編碼
1355178
機械呼吸器市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會與預測,按產品類型、介面、最終用戶、地區、競爭細分Mechanical Ventilators Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Product Type, By Interface, By End User, By Region, Competition |
2022 年全球機械呼吸器市場估值為37 億美元,預計在預測期內將實現強勁成長,到2028 年複合年成長率為6.1%。機械呼吸器是一種在手術或手術期間協助患者呼吸(通氣)的設備。當他們因危重疾病而無法獨立呼吸時。患者透過插入口腔並延伸到主氣道或氣管的中空管(人工氣道)連接到呼吸器。機械通氣的兩種主要方法是正壓通氣(將空氣強制輸送到肺部)和負壓通氣(透過胸部運動將空氣吸入肺部)。機械呼吸器通常用於治療呼吸系統疾病、中風、慢性阻塞性肺病和其他疾病。機械通氣是一種維持生命的技術,可幫助患有嚴重疾病的患者維持重要的呼吸功能。
老年人口的增加:老年人口的成長和慢性呼吸系統疾病的盛行率預計將推動對呼吸器的需求。對肺癌症狀的認知提高以及醫療機構中患者數量的增加促進了呼吸機市場的顯著成長。然而,重要的是要考慮到使用機械通氣可能會帶來某些風險,例如感染風險增加和潛在的肺部損傷。在評估機械呼吸器的市場成長潛力時應考慮這些因素。
市場概況 | |
---|---|
預測期 | 2018-2028 |
2022 年市場規模 | 37.4億美元 |
2028 年市場規模 | 49.8億美元 |
2023-2028 年複合年成長率 | 4.86% |
成長最快的細分市場 | 重症監護室/重症監護室 |
最大的市場 | 北美洲 |
慢性阻塞性肺病(COPD)盛行率激增:慢性阻塞性肺病和其他疾病(包括睡眠呼吸中止症、急性肺損傷和低氧血症)盛行率的上升是市場成長的主要驅動力。此外,早產數量的增加和老年人口的快速成長預計將進一步加速市場擴張。此外,吸菸率高,這是呼吸系統疾病的主要原因,將大大促進市場成長。據世界衛生組織(WHO)稱,目前約90%的慢性阻塞性肺病死亡發生在低收入和中等收入國家。因此,由於此類疾病的盛行率不斷上升、新產品的推出以及用於呼吸治療的經濟高效、攜帶式和方便用戶使用的機械呼吸機的出現,全球市場預計將出現成長。例如,2020 年 8 月,Spicejet 推出了 Spiceoxy,一種攜帶式非侵入性通氣設備。最終用戶的意識不斷提高預計將在預測期內推動需求。
與延長住院時間或醫療機構的長期照護相比,居家醫療保健(包括居家通風)可能更具成本效益。家庭護理還可以透過騰出醫院床位來治療更危急的病例,從而減輕醫療保健系統的負擔。許多患者喜歡在自己舒適的家中接受醫療護理,包括呼吸支持。家庭醫療保健提供了更大的自主權、更好的生活品質,並減少了院內感染的機會。此外,家庭醫療保健的便利性和舒適性等優勢加上成本優勢也有望推動市場成長。此外,醫療基礎設施的增加和可支配收入的增加將導致對家庭醫療保健的高需求,從而成為市場的重要驅動力。此外,患者對呼吸系統疾病的認知不斷提高也緩衝了預測期內市場的成長。
技術進步,例如氣道正壓 (PAP) 設備領域的快速創新、增強的攜帶性以及運輸和攜帶式設備電池壽命的延長,是促進機械呼吸機使用的關鍵驅動力。 2020 年 4 月,InnAccel Technologies 宣布開發出一種非侵入性通氣系統,專為 ICU 治療 COVID-19 患者而設計。該系統在印度設計和製造,可滿足低氧血症惡化患者的需求。此外,該系統的多功能性允許在各種環境和臨床場景中應用,而無需持續供電或訓練有素的呼吸治療師。呼吸器技術進步的出現,加上重症監護病床(ICU)數量的增加,將有助於市場的成長。此外,預計非侵入性呼吸機的日益普及將推動機械呼吸機的需求。非侵入性通氣採用各種介面,並不斷發展以優先考慮患者的舒適度和有效性。近幾十年來,透過鼻腔或面罩輸送的非侵入性通氣在支持慢性和急性通氣衰竭方面已獲得認可。
營運醫院涉及大量固定成本,例如建築維護、公用設施和設備採購。由於農村地區的患者數量較少,這些固定成本成為醫療機構預算的更大負擔。與較大的城市醫院相比,農村醫院獲得資金和財務資源的機會往往有限。他們可能很難投資機械呼吸器等昂貴的醫療設備,這可能會影響患者的照護能力。小型醫療機構面臨的預算限制預計也會限制機械呼吸器的採用。農村和郊區醫院努力為患者提供最高品質的護理,同時克服地理位置偏遠、勞動力有限、規模小和財政資源有限帶來的挑戰。鄉村醫院的患者數量較少,使得這些組織在管理與醫院運作相關的大量固定成本方面面臨挑戰。因此,他們特別容易受到保單和市場變化以及醫療保險和醫療補助付款減少的影響。
呼吸器相關性肺炎是機械通氣患者常見的併發症。當細菌通過呼吸機管進入肺部並導致感染時,就會發生這種情況。 VAP 會延長住院時間並增加發病和死亡的風險。長時間使用呼吸器可能會導致呼吸器依賴,患者變得依賴機器呼吸且難以脫離呼吸器。與機械呼吸器的使用相關的潛在風險可能會阻礙該行業的成長。透過人工氣道引入細菌會帶來感染風險,而肺部微小氣囊的反覆打開和關閉可能會導致肺部損傷。因此,預計這些設備的使用將在預測期內給呼吸機市場帶來挑戰。
與侵入性機械通氣相比,非侵入性通氣併發症的風險較低。插管是一種侵入性操作,可能導致呼吸器相關性肺炎、氣管損傷和呼吸器相關肺損傷等併發症。在某些情況下,NIV 可用於呼吸系統疾病的門診管理,為患者提供在家中或非急診環境中接受治療的靈活性。非侵入性通氣可以作為病人擺脫有創機械通氣的橋樑。它允許逐漸減少呼吸機支持,幫助患者恢復獨立呼吸。人們越來越有興趣開發非侵入性通氣方案,無需插管即可提供有效的呼吸支持。這可以降低與有創機械通氣相關的併發症的風險。
遠端監控使醫療保健專業人員能夠存取患者通氣參數的即時資料,例如潮氣量、呼吸頻率、氣道壓力和氧氣水平。這種連續的資料流提供了有關患者呼吸狀態的寶貴見解,有助於及時做出決策。持續的遠端監控使醫療保健提供者能夠及時發現患者病情的細微變化。資料的突然波動或趨勢可以觸發警報,從而可以進行早期干預並防止潛在的併發症。透過遠端監控,醫療保健專業人員可以最大程度地減少與患者和呼吸機的直接接觸,從而降低潛在的醫療相關感染的風險,特別是在傳染病爆發期間。具有遠端監控功能的呼吸機可以為醫療保健專業人員提供連續的資料流,有助於對機械通氣患者進行早期干預和更好的管理。
根據該產品,預計重症監護室市場在整個預測期內將大幅成長。這種成長可歸因於多種因素,例如呼吸器在急性呼吸衰竭、肺功能受損或任何呼吸相關併發症中提供的臨床益處。這些機械呼吸器廣泛用於確保適當的通風並為醫療機構提供支援。先進的監控和視覺化決策支援是這些機械呼吸器的關鍵促進因素,預計將對預測期內機械呼吸器的市場佔有率產生積極影響。
從最終用戶細分來看,醫院和診所細分市場一直是市場的主導力量。訓練有素的醫療保健提供者的增加有助於呼吸機的有效操作和使用,從而提高醫院的生產力並專注於為客戶提供優質的護理服務。這些因素是市場成長的關鍵驅動力,並將在預測期內繼續推動市場向前發展。該行業的領先企業正在擴大其連鎖醫院,以提高診斷能力並提供有效的治療。這些醫院也投資基礎設施,以提供全面的服務來對抗呼吸道疾病。這些發展,加上客戶對慢性呼吸道疾病醫院治療的日益偏好,促進了醫療機構領域的成長。總體而言,由於這些因素的融合以及醫院提供先進技術和便捷的醫療服務的能力,市場有望成長。
北美地區在 2022 年佔據市場主導地位,主要是由於慢性阻塞性肺病 (COPD) 和需要非侵入性通氣的呼吸系統疾病的盛行率不斷上升。該地區受益於完善的醫療保健基礎設施以及美國新澤西州 Becton、Dickinson 和 Company (BD) 等主要參與者的存在,進一步推動了市場成長。此外,北美地區重症監護入院人數不斷增加,急性無創通氣等新型通氣模式的出現,也促進了機械呼吸器市場的擴大。
此外,亞太地區預計在 2022 年至 2028 年的預測期內將呈現最高的年複合成長率(CAGR)。這種成長可歸因於該地區哮喘和肺癌等呼吸系統疾病盛行率不斷上升等因素。非侵入性通氣和侵入性通氣都屬於所使用的通氣模式。此外,冠狀病毒疾病的日益普遍正在成為亞太地區機械呼吸機市場進步的催化劑。
全球機械呼吸器市場報告以及給定的市場資料,技術科學研究可根據公司的具體需求提供客製化服務。該報告可以使用以下自訂選項:
The Global Mechanical Ventilators Market was valued at USD 3.7 billion in 2022 and is expected to experience robust growth in the forecast period with a CAGR of 6.1% through 2028. A mechanical ventilator is a device that assists patients in breathing (ventilation) during surgeries or when they are unable to breathe independently due to critical illness. Patients are connected to the ventilator through a hollow tube (artificial airway) inserted into their mouth and extending into their main airway or trachea. The two primary methods of mechanical ventilation are positive pressure ventilation, where air is forcibly delivered into the lungs, and negative pressure ventilation, where air is drawn into the lungs through movement of the chest. Mechanical ventilators are commonly used in the treatment of respiratory ailments, strokes, chronic obstructive pulmonary disease, and other medical conditions. Mechanical ventilation is a life-sustaining technique that assists patients with severe illnesses in maintaining vital breathing functions.
Increase in the Geriatric Population: The growing geriatric population and the prevalence of chronic respiratory disorders are expected to drive the demand for ventilators. Increased awareness of lung cancer symptoms and a higher number of patients in medical facilities contribute to significant market growth for ventilators. However, it is important to consider that the use of mechanical ventilation may pose certain risks, such as an increased risk of infection and potential lung damage. These factors should be taken into account when assessing the market growth potential of mechanical ventilators.
Market Overview | |
---|---|
Forecast Period | 2018-2028 |
Market Size 2022 | USD 3.74 Billion |
Market Size 2028 | USD 4.98 Billion |
CAGR 2023-2028 | 4.86% |
Fastest Growing Segment | Intensive Care Unit/Critical Care |
Largest Market | North America |
Surging Prevalence of Chronic Obstructive Pulmonary Disease (COPD): The rising prevalence of COPD and other disorders, including sleep apnea, acute lung injury, and hypoxemia, are the main drivers of market growth. Additionally, the increasing number of preterm births and the rapid growth of the geriatric population are expected to further accelerate market expansion. Furthermore, the high prevalence of tobacco smoking, a leading cause of respiratory diseases, will significantly contribute to market growth. According to the World Health Organization (WHO), currently, around 90% of COPD deaths occur in low- and middle-income countries. As a result, the global market is expected to witness growth due to the increasing prevalence of such diseases, introduction of new products, and the availability of cost-effective, portable, and user-friendly mechanical ventilators for respiratory treatment. For instance, in August 2020, Spicejet introduced Spiceoxy, a portable non-invasive ventilation device. The rising awareness among end users is expected to drive demand in the forecast period.
Home healthcare, including home ventilation, can be more cost-effective compared to extended hospital stays or long-term care in medical facilities. Home care can also reduce the burden on healthcare systems by freeing up hospital beds for more critical cases. Many patients prefer receiving medical care, including ventilatory support, in the comfort of their own homes. Home healthcare offers greater autonomy, better quality of life, and reduced exposure to hospital-acquired infections. Furthermore, the advantages of home healthcare such as convenience and comfort coupled with the cost advantages are also expected to fuel market growth. Additionally, increasing healthcare infrastructure and rising disposable income will lead to high demand for home healthcare, thus acting as a significant driver for the market. Moreover, the rising awareness among the patients regarding the respiratory diseases also cushions the market's growth within the forecasted period.
Technological advancements, such as rapid innovation in the field of Positive Airway Pressure (PAP) devices, enhanced portability, and improved battery life of transport and portable devices, serve as key drivers in promoting the utilization of mechanical ventilators. In April 2020, InnAccel Technologies announced the development of a non-invasive ventilation system designed for ICU use with COVID-19 patients. This system, engineered and manufactured in India, addresses the needs of patients experiencing deteriorating hypoxemia. Furthermore, the versatility of this system allows for application across various settings and clinical scenarios, eliminating the need for continuous electricity or a trained breathing therapist. The emergence of technological advancements in ventilators, combined with the increasing number of intensive care beds (ICU), will contribute to the market's growth. Furthermore, the growing adoption of non-invasive ventilators is anticipated to drive the demand for Mechanical Ventilators. Non-invasive ventilation employs various interfaces and has continuously evolved to prioritize patient comfort and effectiveness. In recent decades, non-invasive ventilation through nasal or facemask delivery has gained recognition in supporting both chronic and acute ventilatory failure.
Operating a hospital involves substantial fixed costs, such as building maintenance, utilities, and equipment purchases. With lower patient volumes in rural areas, these fixed costs become a more significant burden on the facility's budget. Rural hospitals often have limited access to capital and financial resources compared to larger urban hospitals. They may struggle to invest in expensive medical equipment like mechanical ventilators, which can impact patient care capabilities. Budgetary constraints faced by small healthcare facilities are also expected to restrict the adoption of Mechanical Ventilators. Rural and suburban hospitals strive to provide patients with the highest quality of care while simultaneously overcoming challenges posed by their remote geographic location, limited workforce, small size, and constrained financial resources. The low patient volumes in rural hospitals make it challenging for these organizations to manage the significant fixed costs associated with hospital operations. Consequently, they become particularly susceptible to policy and market changes, as well as to Medicare and Medicaid payment reductions.
Ventilator-associated pneumonia is a common complication in patients on mechanical ventilation. It occurs when bacteria enter the lungs through the ventilator tube, leading to infection. VAP can prolong hospital stays and increase the risk of morbidity and mortality. Prolonged ventilator usage can result in ventilator dependency, where the patient becomes reliant on the machine to breathe and has difficulty weaning off the ventilator. The potential risks associated with the utilization of mechanical ventilators may impede the industry's growth. The introduction of germs through the artificial airway poses an infection risk, while the repeated opening and closing of the lungs' microscopic air sacs can lead to lung injury. As a result, the usage of these devices is expected to present challenges to the ventilators market in the forecast period.
Non-invasive ventilation carries a lower risk of complications compared to invasive mechanical ventilation. Intubation is an invasive procedure that can lead to complications such as ventilator-associated pneumonia, tracheal injury, and ventilator-induced lung injury. In some cases, NIV can be used for outpatient management of respiratory conditions, providing patients with the flexibility to receive treatment at home or in a less acute care setting. Non-invasive ventilation can be used as a bridge to wean patients off invasive mechanical ventilation. It allows for a gradual reduction in ventilator support, helping patients regain independent breathing. There is a growing interest in developing non-invasive ventilation options that provide effective respiratory support without the need for intubation. This could reduce the risk of complications associated with invasive mechanical ventilation.
Remote monitoring allows healthcare professionals to access real-time data on patients' ventilatory parameters, such as tidal volume, respiratory rate, airway pressure, and oxygen levels. This continuous data stream provides valuable insights into the patient's respiratory status, facilitating prompt decision-making. Continuous remote monitoring enables healthcare providers to detect subtle changes in the patient's condition promptly. Sudden fluctuations or trends in the data can trigger alerts, allowing for early intervention and preventing potential complications. With remote monitoring, healthcare professionals can minimize direct contact with the patient and the ventilator, reducing the risk of potential healthcare-associated infections, especially during infectious disease outbreaks. Ventilators with remote monitoring capabilities could provide continuous data streams to healthcare professionals, facilitating early intervention and better management of patients on mechanical ventilation.
Based on the product, the intensive care unit segment is anticipated to witness substantial market growth throughout the forecast period. This growth can be attributed to multiple factors, such as the clinical benefits offered by the ventilator in acute respiratory failure, compromised lung functions, or any breathing-related complications. These mechanical ventilators are extensively utilized to ensure proper ventilation and provide support in healthcare facilities. Advanced monitoring and visual decision support are among the key driving factors of these mechanical ventilators, which are expected to have a positive impact on the market share of mechanical ventilators during the forecast period.
Based on the end user segment, the hospital and clinic segment has been the dominant force in the market. The increased availability of trained healthcare providers has contributed to the effective operation and utilization of ventilators, resulting in improved productivity of hospitals and a focus on delivering quality care services to customers. These factors are key drivers of market growth and will continue to propel the market forward during the forecast period. Leading players in the industry are expanding their hospital chains to enhance diagnostic capabilities and provide effective treatment. These hospitals are also investing in infrastructure to offer a comprehensive range of services to combat respiratory diseases. These developments, along with the growing preference among customers for hospital-based treatment of chronic respiratory conditions, contribute to the growth of the healthcare facilities segment. Overall, the market is poised for growth due to the convergence of these factors and the ability of hospitals to offer advanced technologies and convenient access to healthcare services.
North America region dominated the market in 2022, primarily due to the rising prevalence of chronic obstructive pulmonary disease (COPD) and respiratory ailments that necessitate non-invasive ventilation. The region benefits from a well-established healthcare infrastructure and the presence of key players like Becton, Dickinson, and Company (BD) in New Jersey, U.S., further driving market growth. Additionally, the North American region is witnessing increased intensive care admissions and the emergence of novel ventilation modes such as acute non-invasive ventilation, contributing to the expansion of the Mechanical Ventilators Market.
Furthermore, the Asia-Pacific region is projected to exhibit the highest compound annual growth rate (CAGR) during the forecast period of 2022-2028. This growth can be attributed to factors like the escalating prevalence of respiratory ailments like asthma and lung cancer in the region. Both non-invasive ventilation and invasive ventilation are among the modes of ventilation utilized. Moreover, the rising pervasiveness of coronavirus ailment is acting as a catalyst for the progress of the Mechanical Ventilators Market in the Asia-Pacific region.
In this report, the Global Mechanical Ventilators Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Mechanical Ventilators Market.
Global Mechanical Ventilators market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report: